DRUG Stock Price History and Quote Analysis Insights for Investors
Bright Minds Biosciences Inc.
Stock Price Today
Bright Minds Biosciences Inc. (DRUG) stock declined over -5.24%, trading at $38.89 on NASDAQ, down from the previous close of $41.04. The stock opened at $41.99, fluctuating between $38.24 and $41.99 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.
Company Information
| Employees | 0 |
| Beta | 1.13 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | September |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Bright Minds Biosciences Inc. (NASDAQ: DRUG) stock price is $38.89 in the last trading session. During the trading session, DRUG stock reached the peak price of $41.99 while $38.24 was the lowest point it dropped to. The percentage change in DRUG stock occurred in the recent session was -5.24% while the dollar amount for the price change in DRUG stock was -$2.15.
The NASDAQ listed DRUG is part of Biotechnology industry that operates in the broader Healthcare sector. Bright Minds Biosciences Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Ian McDonald
Co-Founder, Chief Executive Officer, Pres & Director
Dr. Jan Torleif Pedersen M.Sc., Ph.D.
Chief Science Officer & Director
Dr. Gideon Shapiro Ph.D.
Vice President of Discovery
Dr. Revati Shreeniwas FCCP, M.D., Ph.D.
Chief Medical Officer
Dr. Emer Leahy M.B.A., Ph.D.
Consultant
DRUG's closing price is 4,081.72% higher than its 52-week low of $0.93 where as its distance from 52-week high of $79.02 is -50.78%.
Number of DRUG employees currently stands at 0.
Official Website of DRUG is: https://brightmindsbio.com
DRUG could be contacted at phone 647 407 2515 and can also be accessed through its website. DRUG operates from 1500 – 1055 West Georgia Street, Vancouver, BC V6E 4N7, Canada.
DRUG stock volume for the day was 48.73K shares. The average number of DRUG shares traded daily for last 3 months was 3.17M.
The market value of DRUG currently stands at $271.80M with its latest stock price at $38.89 and 6.99M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com